The Canadian COVID‑19 Funded Research Database

The University of Calgary

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 41 through 50 of 127 results (Download Results)

Show results per page

Clinical Characteristics and Outcomes of Children Potentially Infected by SARS-CoV-2 Presenting to Pediatric Emergency Departments

Freedman, Stephen B | The University of Calgary | Operating Grant | $788,631

CIHR Alberta 2020

Characterization of interferon-lambda 1 as a treatment for COVID-19

Tyrrell, D. Lorne J | University of Alberta | Operating Grant | $499,775

CIHR Alberta 2020

Development and Evaluation of SARS-CoV-2 RNA Polymerase Inhibitors

Götte, Matthias | University of Alberta | Operating Grant | $675,000

CIHR Alberta 2020

Serological Testing to Outline Protocols for COVID19 in Inflammatory Bowel Disease: STOP COVID‑19 in IBD

Kaplan, Gilaad G | The University of Calgary | Operating Grant | $636,750

CIHR Alberta 2020

Advancing a Potent Inhibitor of SARS-CoV-2 3CL Protease into Clinical Trials

Tyrrell, D. Lorne J | University of Alberta | Operating Grant | $904,236

CIHR Alberta 2020

Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Houghton, Michael | University of Alberta | Operating Grant | $750,000

CIHR Alberta 2020

Vaccination in a pandemic: The impact on routine vaccinations and future COVID‑19 vaccine acceptance

MacDonald, Shannon E | University of Alberta | Operating Grant | $334,908

CIHR Alberta 2020

Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $311,000

CIHR Alberta 2020

Therapeutic approaches to SARS-CoV-2 and other pathogenic coronaviruses

Hobman, Tom C | University of Alberta | Operating Grant | $998,300

CIHR Alberta 2020

Broad-spectrum Antiviral Nasal Spray to Prevent and treat Infection by SARS-CoV2 and Seasonal Respiratory Viruses in High Risk Patients and Health Care Providers

Marchant, David J | University of Alberta | Operating Grant | $662,480

CIHR Alberta 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Clinical Characteristics and Outcomes of Children Potentially Infected by SARS-CoV-2 Presenting to Pediatric Emergency Departments

Characterization of interferon-lambda 1 as a treatment for COVID-19

Development and Evaluation of SARS-CoV-2 RNA Polymerase Inhibitors

Serological Testing to Outline Protocols for COVID19 in Inflammatory Bowel Disease: STOP COVID‑19 in IBD

Advancing a Potent Inhibitor of SARS-CoV-2 3CL Protease into Clinical Trials

Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Vaccination in a pandemic: The impact on routine vaccinations and future COVID‑19 vaccine acceptance

Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

Therapeutic approaches to SARS-CoV-2 and other pathogenic coronaviruses

Broad-spectrum Antiviral Nasal Spray to Prevent and treat Infection by SARS-CoV2 and Seasonal Respiratory Viruses in High Risk Patients and Health Care Providers